LG CNS and POSCO Tokenize Live Receivables on Injective
LG CNS and POSCO International launched a 2026 pilot to tokenize live trade receivables on the Injective blockchain using commercial data from more than 80 overseas branches.
LG CNS and POSCO International launched a pilot in 2026 to convert live trade accounts receivable into permissioned tokens on the Injective blockchain using commercial data from more than 80 POSCO overseas branches.
Under the pilot, receivables created by POSCO International’s subsidiaries are issued as permissioned tokens that carry compliance rules. Authorized parties can hold and transfer the tokens while POSCO International’s finance teams retain settlement controls. The project uses actual transaction data from overseas branches rather than simulated inputs and aims to replace separate ledgers kept by subsidiaries, banks and counterparties with a single shared record that keeps compliance checks attached to the asset as it moves across borders.
Injective’s real‑world asset module enforces identity verification and holding rules at the protocol level. The network provides near‑instant finality, produces blocks in under a second and uses an onchain order book designed to prevent front‑running. Project partners said those features are required when tokenizing receivables that represent actual money owed.
POSCO International reported $22.2 billion in revenue and operates more than 80 overseas branches serving steel, energy and battery materials markets. LG CNS, the information technology unit of LG Group, completed a public listing in February 2025. LG CNS has provided digital currency infrastructure to over 220 local governments, participated in the Bank of Korea’s CBDC pilot, and operates security token platforms for KOSCOM and Mirae Asset Securities. In March 2026 LG CNS entered a partnership with Palantir to deploy enterprise AI across the LG Group.
POSCO International plans to finalize a pilot operation framework in the second half of 2026 and to apply confirmed efficiency gains in a phased rollout across its global operations. The companies cited faster settlement than the current multi‑day cycle and consistent compliance across jurisdictions as objectives for the framework.
A POSCO International spokesperson commented: “The pilot validated the applicability of AI and blockchain technology based on real trade data and processes. We will focus rollout on areas where operational efficiency gains were confirmed.” Eric Chem, Injective’s co‑founder, added: “When South Korea’s largest trading company and LG CNS choose Injective for live trade receivables, it demonstrates Injective’s ability to move real capital markets onchain.”
Industry participants continue to test tokenized real‑world asset models. JPMorgan’s Kinexys platform has processed more than $3 trillion in cumulative transactions, and several global banks and asset managers have tested tokenized private‑market and receivable products. Wider adoption of tokenized receivables depends on regulatory clarity, platform interoperability and distribution channels, areas that market participants are developing and testing.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.








